Save the Date
EVENT:  Princess Margaret Hematology Conference

FOR MORE INFORMATION:
Email: conferences@uhn.ca

Website: https://events.myconferencesuite.com/PMHC2026

ABOUT THE CONFERENCE:

The Princess Margaret Hematology Conference (PMHC), held in collaboration with the International Lymphoma Radiation Oncology Group (ILROG), is a landmark inaugural event within the Malignant Hematology Program at the Princess Margaret Cancer Centre, one of the world’s leading cancer research and treatment institutions. This prestigious conference is designed to foster collaboration, innovation, and knowledge exchange among national and international experts, researchers, clinicians, and other professionals dedicated to advancing the field of hematologic malignancies, including leukemia, lymphoma, myeloma, and related disorders as well as the recent developments in allogeneic/ autologous hematopoietic stem cell transplantation and immune cellular therapy for the treatment of hematologic cancers.

This is a two and a half day scientific forum which aims to serve as a premier platform for discussing the latest advancements in clinical and basic research, as well as the development of cutting-edge clinical studies in hematologic cancers. By bringing together a diverse group of stakeholders—renowned oncologists, hematologists, radiation oncologists, researchers, translational scientists, and allied health professionals—the conference will facilitate interdisciplinary dialogue to address the most pressing challenges and opportunities in the field. This includes keynote speakers, plenary and breakout sessions, poster presentations, debate and networking opportunities at the welcome reception.

KEY DATES:

Registration Opens: December 16, 2025
Call for Abstracts Opens: December 16, 2025
Deadline for Abstract Submission: January 26, 2026